pyrimethamine has been researched along with Complications, Pregnancy in 33 studies
Maloprim: contains above 2 cpds
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mefloquine was more efficacious than sulfadoxine-pyrimethamine in HIV-uninfected women or daily cotrimoxazole prophylaxis in HIV-infected pregnant women for prevention of malaria infection and was associated with lower risk of maternal anaemia, no adverse effects on pregnancy outcomes (such as stillbirths and abortions), and no effects on low birth weight and prematurity." | 8.98 | Mefloquine for preventing malaria in pregnant women. ( Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO, 2018) |
| "Increasing resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine (SP) threatens its usefulness for intermittent preventive treatment in pregnancy (IPTp-SP)." | 8.02 | Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo. ( DeMol, P; Devleesschauwer, B; Hayette, MP; Kabututu, PZ; Kayiba, NK; Lusamba, PD; Mukomena, ES; Mvumbi, DM; Mvumbi, GL; Rosas-Aguirre, A; Speybroeck, N; Tchakounang, VRK; Yobi, DM, 2021) |
| "Intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is widely recommended in sub-Saharan Africa to reduce the risk of malaria and improve birth outcomes." | 7.79 | Intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda. ( Ades, V; Arinaitwe, E; Chang, M; Dorsey, G; Filler, S; Kamya, MR; Mugagga, O; Nasr, S; Ninsiima, B; Patil, TS; Schwartz, A; Walakira, A, 2013) |
| "The World Health Organization (WHO) recommends using insecticide-treated mosquito nets (ITNs) and intermittent preventive treatment with sulphadoxine-pyrimethamine (IPT-SP) to prevent malaria in sub-Saharan Africa." | 7.77 | Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire. ( Coffie, PA; Dabis, F; Eholie, SP; Ekouevi, DK; Kanhon, S; Kone, M; Kouakou, F; Menan, H; Sloan, C; Vanga-Bosson, HA, 2011) |
| "Mefloquine was more efficacious than sulfadoxine-pyrimethamine in HIV-uninfected women or daily cotrimoxazole prophylaxis in HIV-infected pregnant women for prevention of malaria infection and was associated with lower risk of maternal anaemia, no adverse effects on pregnancy outcomes (such as stillbirths and abortions), and no effects on low birth weight and prematurity." | 4.98 | Mefloquine for preventing malaria in pregnant women. ( Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO, 2018) |
| "Intermittent preventive treatment (IPTp) for pregnant women with sulfadoxine-pyrimethamine (SP) is widely implemented for the prevention of malaria in pregnancy and adverse birth outcomes." | 4.31 | Impact of Intermittent Presumptive Treatment for Malaria in Pregnancy on Hospital Birth Outcomes on the Kenyan Coast. ( Amadi, D; Bejon, P; Berkley, JA; Kamau, A; Musau, M; Mwakio, S; Nyaguara, A; Seale, AC; Snow, RW, 2023) |
| "Increasing resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine (SP) threatens its usefulness for intermittent preventive treatment in pregnancy (IPTp-SP)." | 4.02 | Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo. ( DeMol, P; Devleesschauwer, B; Hayette, MP; Kabututu, PZ; Kayiba, NK; Lusamba, PD; Mukomena, ES; Mvumbi, DM; Mvumbi, GL; Rosas-Aguirre, A; Speybroeck, N; Tchakounang, VRK; Yobi, DM, 2021) |
| "In 2005, Nigeria changed its policy on prevention of malaria in pregnancy to intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP)." | 3.88 | Prevalence of Low Birth Weight before and after Policy Change to IPTp-SP in Two Selected Hospitals in Southern Nigeria: Eleven-Year Retrospective Analyses. ( Adibe, MO; Aguwa, NC; Igboeli, NU; Ukwe, CV, 2018) |
| "At least 39 sub-Saharan African countries have policies on preventing malaria in pregnancy (MIP), including use of long-lasting insecticidal nets (LLINs), intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) and case management." | 3.80 | Assessment of the consistency of national-level policies and guidelines for malaria in pregnancy in five African countries. ( Andre, ZH; Dickerson, A; Eckert, E; Gomez, PP; Gutman, J; Hamel, MJ; Roman, E; Youll, S, 2014) |
| "Intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is widely recommended in sub-Saharan Africa to reduce the risk of malaria and improve birth outcomes." | 3.79 | Intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda. ( Ades, V; Arinaitwe, E; Chang, M; Dorsey, G; Filler, S; Kamya, MR; Mugagga, O; Nasr, S; Ninsiima, B; Patil, TS; Schwartz, A; Walakira, A, 2013) |
| "The World Health Organization (WHO) recommends using insecticide-treated mosquito nets (ITNs) and intermittent preventive treatment with sulphadoxine-pyrimethamine (IPT-SP) to prevent malaria in sub-Saharan Africa." | 3.77 | Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire. ( Coffie, PA; Dabis, F; Eholie, SP; Ekouevi, DK; Kanhon, S; Kone, M; Kouakou, F; Menan, H; Sloan, C; Vanga-Bosson, HA, 2011) |
| " We recorded demographic data, antenatal prescription of intermittent preventive therapy during pregnancy with sulfadoxine-pyrimethamine and bed net use, and examined finger-prick blood for malaria parasites and hemoglobin concentration." | 3.76 | Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets. ( Chaluluka, E; Feng, G; Molyneux, ME; Rogerson, SJ; Simpson, JA, 2010) |
| "Burkina Faso has recently changed the antimalarial drug policy to artesunate/amodiaquine or artemether/lumefantrine as the first-line antimalarial drug and sulfadoxine/pyrimethamine for the intermittent preventive treatment in pregnant woman." | 3.75 | [Change of antimalarial first-line treatment in Burkina Faso in 2005]. ( Diarra, A; Gansané, A; Konaté, AT; Nébié, I; Ouédraogo, A; Sirima, BS; Soulama, I; Tiono, A, 2009) |
| "The treatment of reference of congenital toxoplasmosis combines two folate synthesis inhibitors, pyrimethamine and an antibacterial sulfamide (sulfadiazine or sulfadoxine)." | 1.32 | [Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis]. ( Coutty, N; Decocq, J; Delahousse, G; Detourmignies, L; Le Goueff, F; Mubiayi, N, 2004) |
| "We describe the case of a patient with systemic lupus erythematosus, treated by corticosteroids, who presented during two successive pregnancies with serological reactivation of toxoplasmosis associated with fetal lesions." | 1.29 | Recurrent congenital toxoplasmosis in a woman with lupus erythematosus. ( Blanc, B; Boubli, L; Casta, M; Chagnon, C; Cravello, L; D'Ercole, C; Franck, J; Harle, JR; Leclaire, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (45.45) | 18.7374 |
| 1990's | 2 (6.06) | 18.2507 |
| 2000's | 2 (6.06) | 29.6817 |
| 2010's | 12 (36.36) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Kamau, A | 1 |
| Musau, M | 1 |
| Mwakio, S | 1 |
| Amadi, D | 1 |
| Nyaguara, A | 1 |
| Bejon, P | 1 |
| Seale, AC | 1 |
| Berkley, JA | 1 |
| Snow, RW | 1 |
| Kayiba, NK | 1 |
| Yobi, DM | 1 |
| Tchakounang, VRK | 1 |
| Mvumbi, DM | 1 |
| Kabututu, PZ | 1 |
| Devleesschauwer, B | 1 |
| Mukomena, ES | 1 |
| DeMol, P | 1 |
| Hayette, MP | 1 |
| Mvumbi, GL | 1 |
| Rosas-Aguirre, A | 1 |
| Lusamba, PD | 1 |
| Speybroeck, N | 1 |
| Velter, C | 1 |
| Hotz, C | 1 |
| Ingen-Housz-Oro, S | 1 |
| Wolkenstein, P | 1 |
| Fardet, L | 1 |
| Igboeli, NU | 1 |
| Adibe, MO | 1 |
| Ukwe, CV | 1 |
| Aguwa, NC | 1 |
| Leke, AZ | 1 |
| Dolk, H | 1 |
| Loane, M | 1 |
| Casson, K | 1 |
| Maboh, NM | 1 |
| Maeya, SE | 1 |
| Ndumbe, LD | 1 |
| Nyenti, PB | 1 |
| Armstrong, O | 1 |
| Etiendem, D | 1 |
| González, R | 1 |
| Pons-Duran, C | 1 |
| Piqueras, M | 1 |
| Aponte, JJ | 1 |
| Ter Kuile, FO | 1 |
| Menéndez, C | 1 |
| Arinaitwe, E | 1 |
| Ades, V | 1 |
| Walakira, A | 1 |
| Ninsiima, B | 1 |
| Mugagga, O | 1 |
| Patil, TS | 1 |
| Schwartz, A | 1 |
| Kamya, MR | 1 |
| Nasr, S | 1 |
| Chang, M | 1 |
| Filler, S | 1 |
| Dorsey, G | 1 |
| Gomez, PP | 1 |
| Gutman, J | 1 |
| Roman, E | 1 |
| Dickerson, A | 1 |
| Andre, ZH | 1 |
| Youll, S | 1 |
| Eckert, E | 1 |
| Hamel, MJ | 1 |
| Mosha, D | 1 |
| Chilongola, J | 1 |
| Ndeserua, R | 1 |
| Mwingira, F | 1 |
| Genton, B | 1 |
| Gansané, A | 1 |
| Nébié, I | 1 |
| Soulama, I | 1 |
| Tiono, A | 1 |
| Diarra, A | 1 |
| Konaté, AT | 1 |
| Ouédraogo, A | 1 |
| Sirima, BS | 1 |
| Feng, G | 1 |
| Simpson, JA | 1 |
| Chaluluka, E | 1 |
| Molyneux, ME | 1 |
| Rogerson, SJ | 1 |
| Grietens, KP | 1 |
| Gies, S | 1 |
| Coulibaly, SO | 1 |
| Ky, C | 1 |
| Somda, J | 1 |
| Toomer, E | 1 |
| Muela Ribera, J | 1 |
| D'Alessandro, U | 1 |
| Maiga, AS | 1 |
| Diakite, M | 1 |
| Diawara, A | 1 |
| Sango, HA | 1 |
| Coulibaly, CO | 1 |
| Vanga-Bosson, HA | 1 |
| Coffie, PA | 1 |
| Kanhon, S | 1 |
| Sloan, C | 1 |
| Kouakou, F | 1 |
| Eholie, SP | 1 |
| Kone, M | 1 |
| Dabis, F | 1 |
| Menan, H | 1 |
| Ekouevi, DK | 1 |
| Bertin, G | 1 |
| Briand, V | 1 |
| Bonaventure, D | 1 |
| Carrieu, A | 1 |
| Massougbodji, A | 1 |
| Cot, M | 1 |
| Deloron, P | 1 |
| FILIPOWSKA, I | 1 |
| BARBAROWSKI, H | 1 |
| ISBRUCH, F | 1 |
| THALHAMMER, O | 1 |
| DELERUE, J | 1 |
| MORLEY, D | 1 |
| WOODLAND, M | 1 |
| CUTHBERTSON, WF | 1 |
| BEER, K | 1 |
| OCKLITZ, HW | 1 |
| SCHMITZ, HH | 1 |
| ZIESCHE, H | 1 |
| TENHUNEN, A | 1 |
| ALEXANDER, M | 1 |
| PULLON, DH | 1 |
| Mubiayi, N | 1 |
| Coutty, N | 1 |
| Detourmignies, L | 1 |
| Le Goueff, F | 1 |
| Decocq, J | 1 |
| Delahousse, G | 1 |
| D'Ercole, C | 1 |
| Boubli, L | 1 |
| Franck, J | 1 |
| Casta, M | 1 |
| Harle, JR | 1 |
| Chagnon, C | 1 |
| Cravello, L | 1 |
| Leclaire, M | 1 |
| Blanc, B | 1 |
| Cultrera, R | 1 |
| Contini, C | 1 |
| Hoffbrand, AV | 1 |
| Schubert, S | 1 |
| Granz, W | 1 |
| Kupferschmidt, HG | 1 |
| Harrison, KA | 1 |
| Ibeziako, PA | 1 |
| Prozorovskiĭ, VB | 1 |
| Malakhovskiĭ, VG | 1 |
| Fleming, AF | 1 |
| Hendrickse, JP | 1 |
| Allan, NC | 1 |
1 review available for pyrimethamine and Complications, Pregnancy
| Article | Year |
|---|---|
Mefloquine for preventing malaria in pregnant women.
Topics: Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; HIV Seronegativity; Hum | 2018 |
1 trial available for pyrimethamine and Complications, Pregnancy
| Article | Year |
|---|---|
[Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].
Topics: Adolescent; Adult; Anemia; Antimalarials; Drug Administration Schedule; Drug Combinations; Endemic D | 2010 |
31 other studies available for pyrimethamine and Complications, Pregnancy
| Article | Year |
|---|---|
Impact of Intermittent Presumptive Treatment for Malaria in Pregnancy on Hospital Birth Outcomes on the Kenyan Coast.
Topics: Antimalarials; Drug Combinations; Female; Humans; Kenya; Malaria; Pregnancy; Pregnancy Complications | 2023 |
Evaluation of the usefulness of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in a context with increased resistance of Plasmodium falciparum in Kingasani Hospital, Kinshasa in the Democratic Republic of Congo.
Topics: Adolescent; Adult; Antimalarials; Democratic Republic of the Congo; Drug Combinations; Drug Resistan | 2021 |
Stevens-Johnson Syndrome During Pregnancy: Case Report of a Newborn Treated With the Culprit Drug.
Topics: Adult; Cesarean Section; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Pregna | 2018 |
Prevalence of Low Birth Weight before and after Policy Change to IPTp-SP in Two Selected Hospitals in Southern Nigeria: Eleven-Year Retrospective Analyses.
Topics: Adult; Drug Combinations; Female; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Mala | 2018 |
First trimester medication use in pregnancy in Cameroon: a multi-hospital survey.
Topics: Adult; Analgesics; Anti-Bacterial Agents; Antimalarials; Cameroon; Drug Combinations; Drug Prescript | 2018 |
Intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda.
Topics: Adult; Cross-Sectional Studies; Dihydropteroate Synthase; Documentation; Drug Combinations; Drug Res | 2013 |
Assessment of the consistency of national-level policies and guidelines for malaria in pregnancy in five African countries.
Topics: Africa; Antimalarials; Chemoprevention; Drug Combinations; Female; Health Policy; Health Services Re | 2014 |
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
Topics: Adult; Anemia; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Low Birth Wei | 2014 |
[Change of antimalarial first-line treatment in Burkina Faso in 2005].
Topics: Animals; Antimalarials; Burkina Faso; Child, Preschool; Chloroquine; Female; Health Policy; Hemoglob | 2009 |
Decreasing burden of malaria in pregnancy in Malawian women and its relationship to use of intermittent preventive therapy or bed nets.
Topics: Drug Combinations; Female; Hospitals; Humans; Longitudinal Studies; Malaria; Malawi; Mosquito Nets; | 2010 |
Bottlenecks for high coverage of intermittent preventive treatment in pregnancy: the case of adolescent pregnancies in rural Burkina Faso.
Topics: Adolescent; Age Distribution; Attitude to Health; Burkina Faso; Drug Combinations; Female; Health Pr | 2010 |
Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire.
Topics: Adolescent; Adult; Chemoprevention; Cote d'Ivoire; Cross-Sectional Studies; Drug Combinations; Drug | 2011 |
Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Topics: Adult; Antimalarials; Benin; Biomarkers; Chemoprevention; Clinical Trials as Topic; Dihydropteroate | 2011 |
[Observations on daraprim and sulfonamide therapy of latent toxoplasmosis in women].
Topics: Antimalarials; Female; Humans; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfanilamide; Sul | 1958 |
[Contributions to the problem of toxoplasmosis. I. Should we, at the present state of knowledge, treat pregnant women with positive toxoplasmosis titers, with daraprim and supronal?].
Topics: Antimalarials; Drug Combinations; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadiazine; S | 1960 |
[The diagnosis and therapy of a toxoplasmosis infection in pregnancy. Birth of a healthy child in sulfonamide-pyrimethamine-treated lymph node toxoplasmosis in the 4th and 5th month of pregnancy].
Topics: Antimalarials; Female; Humans; Lymph Nodes; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfa | 1960 |
[TERATOGENIC ACTION OF DRUGS IN THE PREGNANT WOMAN].
Topics: Abnormalities, Drug-Induced; Antineoplastic Agents; Avitaminosis; Chlorpromazine; Cortisone; Female; | 1963 |
CONTROLLED TRIAL OF PYRIMETHAMINE IN PREGNANT WOMEN IN AN AFRICAN VILLAGE.
Topics: Birth Weight; Chloroquine; Female; Humans; Infant; Infant Mortality; Lactose; Malaria; Nigeria; Preg | 1964 |
[ACQUIRED TOXOPLASMOSIS].
Topics: Communicable Disease Control; Communicable Diseases; Female; Humans; Pregnancy; Pregnancy Complicati | 1963 |
[PREVENTION AND THERAPY OF CONNATAL TOXOPLASMOSIS].
Topics: Communicable Diseases; Epidemiology; Female; Humans; Infant; Infant, Newborn; Pregnancy; Pregnancy C | 1963 |
GLANDULAR TOXOPLASMOSIS. OCCURRENCE OF THE DISEASE IN FINLAND.
Topics: Biopsy; Diagnosis, Differential; Epidemiology; Female; Finland; Hodgkin Disease; Humans; Lymph Node | 1964 |
[TOXOPLASMOSIS IN ADULTS].
Topics: Adult; Diagnosis; Encephalomyelitis; Female; Humans; Meningoencephalitis; Pregnancy; Pregnancy Compl | 1965 |
THE TREATMENT OF GLANDULAR TOXOPLASMOSIS.
Topics: Child; Choroiditis; Drug Therapy; Female; Folic Acid; Humans; Lung Diseases; Lymphadenitis; Meningit | 1965 |
[Maternal pancytopenia during antenatal treatment of congenital toxoplasmosis].
Topics: Adult; Antiprotozoal Agents; Drug Therapy, Combination; Female; Humans; Pancytopenia; Parity; Pregna | 2004 |
Recurrent congenital toxoplasmosis in a woman with lupus erythematosus.
Topics: Adult; Amniotic Fluid; Animals; Anti-Infective Agents; Antibodies, Protozoan; Female; Fetal Diseases | 1995 |
Management of a case of chloroquine-resistant falciparum malaria in a pregnant woman with glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Topics: Adult; Animals; Antimalarials; Chloroquine; Drug Resistance, Microbial; Drug Therapy, Combination; F | 1999 |
Pathology of folate deficiency.
Topics: Anemia, Megaloblastic; Female; Folic Acid Deficiency; Humans; Infertility; Male; Methotrexate; Pigme | 1977 |
[Remarks on the drug prevention of malaria].
Topics: Adult; Antimalarials; Child; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resi | 1985 |
Maternal anaemia and fetal birthweight.
Topics: Anemia; Anemia, Sickle Cell; Birth Weight; Blood Transfusion; Body Height; Chloroquine; Embryonic an | 1973 |
[Range of teratogenic action as an indication of danger in using a medicinal preparation during pregnancy].
Topics: Abnormalities, Drug-Induced; Animals; Busulfan; Female; Pregnancy; Pregnancy Complications; Pyrimeth | 1970 |
The prevention of megaloblastic anaemia in pregnancy in Nigeria.
Topics: Anemia, Hypochromic; Anemia, Macrocytic; Female; Folic Acid; Hemolysis; Humans; Malaria; Nigeria; Pr | 1968 |